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Zebrafish are a unique cell to behavior model for studying the basic biology of
human inherited neurological conditions. Conserved vertebrate genetics and optical
transparency provide in vivo access to the developing nervous system as well as
high-throughput approaches for drug screens. Here we review zebrafish modeling
for two broad groups of inherited conditions that each share genetic and molecular
pathways and overlap phenotypically: neurodevelopmental disorders such as Autism
Spectrum Disorders (ASD), Intellectual Disability (ID) and Schizophrenia (SCZ), and
neurodegenerative diseases, such as Cerebellar Ataxia (CATX), Hereditary Spastic
Paraplegia (HSP) and Charcot-Marie Tooth Disease (CMT). We also conduct a small
meta-analysis of zebrafish orthologs of high confidence neurodevelopmental disorder
and neurodegenerative disease genes by looking at duplication rates and relative protein
sizes. In the past zebrafish genetic models of these neurodevelopmental disorders and
neurodegenerative diseases have provided insight into cellular, circuit and behavioral
level mechanisms contributing to these conditions. Moving forward, advances in genetic
manipulation, live imaging of neuronal activity and automated high-throughput molecular
screening promise to help delineate the mechanistic relationships between different
types of neurological conditions and accelerate discovery of therapeutic strategies.
Keywords: zebrafish, disease modeling, autism spectrum disorder, intellectual disability, schizophrenia, ataxia,
Charcot-Marie tooth, hereditary spastic paraplegia
INTRODUCTION
As genetically tractable vertebrates (Streisinger et al., 1981) that share with humans many pathways
targeted by FDA approved pharmaceuticals (Renier et al., 2007; Rihel et al., 2010) zebrafish are
a powerful model for inherited neurological conditions, both in terms of delineating underlying
mechanisms and developing therapeutic strategies. Their small size and optical transparency
enable in vivo visualization of cell- and systems-level processes throughout early developmental
stages (McLean and Fetcho, 2011; Rasmussen and Sagasti, 2016) while, precocious development
of quantifiable behaviors (Brustein et al., 2003) and reduced complexity of the zebrafish nervous
system (Goulding, 2009) simplify functional studies of neural circuits. These advantages combined
with conserved vertebrate genetics lend themselves to keeping pace with the extraordinary
discovery rate of genetic mutations that cause inherited neurological conditions in humans. With
the sequencing of the human genome, the formation of worldwide consortia of human geneticists
and clinicians and ever-cheaper sequencing technologies, these discoveries have revealed that many
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inherited disorders with related clinical diagnoses consist of large
sets of rare molecular genetic variation (Buxbaum et al., 2012;
Gonzalez et al., 2015). Here we focus on these parallel and
synergistic frontiers of disease gene discovery and systems-level
analyses in zebrafish that promise to yield insight into disease
mechanisms and therapies.
To assess zebrafish as a model, we compare studies
of two broad classes of inherited neurological conditions:
developmental disorders and degenerative diseases, with each
class presenting a spectrum of overlapping genotypes and
phenotypes. For developmental disorders, we include Autism
Spectrum Disorders (ASD), Intellectual Disability (ID) and
Schizophrenia (SCZ) that can all affect executive functions,
social and overall intellectual abilities (American Psychiatric
Association, and DSM-5 Task Force, 2013). Such disorders
can co-occur in the same individual (Amaral et al., 2011)
supporting overlapping disease etiologies. The second general
class we consider are a subset of degenerative diseases including
Cerebellar Ataxia (CATX), Hereditary Spastic Paraplegia (HSP),
spinal motor atrophy (SMA), amyotrophic lateral sclerosis
(ALS) and Charcot-Marie Tooth Disease (CMT) that impair
movement due to degeneration of long axon tracts (Züchner
and Vance, 2005). In both developmental and degenerative
cases there are examples of: (1) distinct clinical features
within a given class that result from mutations in the same
genes; and (2) shared clinical phenotypes produced by many
different types of genetic mutation (Espinós and Palau, 2009;
Kaufman et al., 2010; Timmerman et al., 2013; Vissers et al.,
2016). For example, ASD affects roughly 1% of the population
but even the most commonly mutated genes only account
for 1–3% of ASD with hundreds of suspected causal loci
(Miles, 2011; De Rubeis and Buxbaum, 2015; Geschwind and
State, 2015). It is likely that these two groupings also have
phenotypic overlap since age of onset and progression of
symptoms varies within each grouping. For example, SCZ
that we group with ‘‘developmental’’ disorders also shares
symptoms with neurodegenerative conditions. None-the-less,
by reviewing the literature on zebrafish models of these two
groups of disorders, we hope to highlight the role we feel the
zebrafish model has to play in revealing grouped mechanisms
of shared clinical features that result from diverse genetic
mutations.
COMPARING HUMAN AND ZEBRAFISH
BRAINS AND GENETICS
In addition to significant advantages of using zebrafish to model
human disease, there are also challenges to modeling disease
conditions in zebrafish. For example, in HSP symptoms are
associated with degeneration of corticospinal tracts that have
no clear homologous cell type in zebrafish. Moreover, for
many human brain regions, the baseline studies to determine
whether some of these brain regions function similarly to
humans still need to be done. Finally, in terms of genetics,
zebrafish have retained gene duplicates from a ray-finned
fish whole genome duplication (Glasauer and Neuhauss, 2014)
that likely provides both advantages (sub-functionalization of
pleiotropic phenotypes) and disadvantages (genetic redundancy)
for generating disease models.
Conserved Brain Regions?
Many brain regions relevant to human disease show molecular
and structural homology in zebrafish (Figure 1). Gene expression
patterns that molecularly define large-scale regions of fore-,
mid-, hindbrain and spinal cord of the central nervous system
(CNS) are generally conserved in vertebrates (Myers et al.,
1986; Lumsden and Krumlauf, 1996; Wurst and Bally-Cuif,
2001; McLean et al., 2007; Wullimann et al., 2011). These
major regions exhibit both neurochemical identities (e.g.,
neurotransmitters and receptors; Higashijima et al., 2004; Renier
et al., 2007; Jones et al., 2015) and regional connectivity of
sub-structures, including the thalamus (Mueller, 2012), optic
tectum (Wullimann, 1994), hypothalamic regulatory nuclei
(Herget et al., 2014), cerebellum (Hashimoto and Hibi, 2012),
medulla oblongata (Kinkhabwala et al., 2011; Koyama et al.,
2011), and spinal cord (Higashijima et al., 2004; Wen and
Brehm, 2005). Determining homology between human and
zebrafish forebrain structures is more challenging because
of developmental differences affecting telencephalon topology
(eversion vs. invagination) and the elaboration of themammalian
cerebrum (Striedter, 2005). Recent studies have made headway
supporting the existence of zebrafish basal ganglia- (Filippi
et al., 2014; Wullimann, 2014), cortex- (Ganz et al., 2014),
amygdala- (Maximino et al., 2013) and hippocampus-like
circuits (O’Connell and Hofmann, 2011; Maximino et al.,
2013; Ganz et al., 2014). While these studies support the
existence of structurally homologous brain regions, work is still
needed to resolve connectivity and functional homology among
fore- and midbrain structures. Furthermore some structures
in the human brain appear absent in zebrafish including
the pons (Wullimann et al., 2011), cortico-thalamic (Mueller,
2012) and cortico-spinal tracts (Babin et al., 2014). With
these detailed analyses, we have the necessary anatomical
map needed for neurological disease research that is quickly
being enriched by functional studies to test the relevance to
these brain regions for both zebrafish behaviors and human
disorders.
To address the involvement of brain regions in a particular
behavior, advances in functional imaging have been critical.
Importantly, these studies focus on larval stages, 5–7 post
fertilization, when it is possible to image the entire brain
and the larva has already acquired an impressive repertoire
of behaviors (Haesemeyer and Schier, 2015). For example,
recent studies support functional homology of the zebrafish
cerebellum during visual-motor behaviors (Hsieh et al., 2014;
Matsui et al., 2014). These findings were made possible by
combining behavioral experiments with both genetically
encoded calcium imaging to visualize neuronal activity (Matsui
et al., 2014) and loose patch recordings from cerebellar
Purkinje neurons (Hsieh et al., 2014). These pioneering studies
now open the door to sophisticated functional modeling
of cerebellar-based neuropathies that can manifest in both
neurodevelopmental disorders and neurodegenerative diseases,
particularly CATX. Extending these functional technologies
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FIGURE 1 | Proposed structural homology between zebrafish and humans for brain regions associated with human neurodevelopmental disorders
and neurodegenerative diseases. (A) Adult zebrafish sections for I. telencephalon, brain and II. spinal chord. (B) Adult human sections for i., ii. telencephalon
(anterior forebrain), brain and iii. spinal chord (transverse). Two hemi-sections were used (i. and ii.) to illustrate basal ganglia, hippocampus and amygdala. Regions
associated with developmental disorders (blue) include cortical and subcortical structures that are vital for language, communication, memory, emotion and
intellectual ability (Amaral et al., 2011; Bakhshi and Chance, 2015; Hampson and Blatt, 2015). Homologous forebrain regions for zebrafish are based on models that
propose vertebrate structures that may be conserved for aspects of cognition and emotional behavior (Mueller and Wullimann, 2009; Mueller, 2012; Maximino et al.,
2013; Filippi et al., 2014; Ganz et al., 2014; Wullimann, 2014). Conserved regions associated with axon degenerative diseases (red) include portions of the motor
circuit and optic nerve (De Jonghe et al., 1997; Abrams et al., 2015). Zebrafish brain illustrations were adapted from Wullimann et al. (1996) and Mueller (2012). Am,
amygdala; BG, basal ganglia; Ce, cerebellum; Ctx, cortex; Dc, dorsal central pallium; Dl, dorsal lateral pallium; Dm, dorsal medial pallium; DTele, dorsal
telencephalon; Hip, hippocampus; Hy, hypothalamus; MN, motor neuron; PT, posterior tuberculum; Th, thalamus; ON, optic nerve.
to forebrain circuits will be essential to support past studies
suggesting similar cognitive and emotional functions exist
in subdivisions of the zebrafish forebrain (Northcutt,
2006; O’Connell and Hofmann, 2011; Maximino et al.,
2013).
Conserved Genomes?
Human and zebrafish genomes are highly conserved, with
76–82% of human disease genes present in zebrafish and an
average of 20–24% of zebrafish genes duplicated (Howe et al.,
2013). In some cases duplicates become sub-functionalized
providing an advantage for studying pleiotropic phenotypes
(Fleisch et al., 2008; Good et al., 2012; Lagman et al., 2015);
in other cases, duplicates have redundant functions providing
phenotypic buffering and complicating the generation of disease
models (Hinits et al., 2012; Manoli and Driever, 2014). To
determine if genes linked to a particular human neurological
condition are enriched in gene duplicates we compared gene
duplication rates in disease gene orthologs. Because past
studies have shown duplicate enrichment in genes associated
with neuronal development, signaling pathways and neuronal
activity (Howe et al., 2013; Glasauer and Neuhauss, 2014),
we hypothesized that neurodevelopmental duplicates would
have a higher retention rate compared to neurodegenerative
duplicates. Several gene sets showed a high duplicate retention
frequency: over 60% (ASD-ID) and 45% (ASD and CMT;
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FIGURE 2 | Zebrafish orthologs of human neurological disease genes
vary with respect to duplicate retention and average protein size. (A)
Gene duplicate retention rates in zebrafish are graphed for
neurodevelopmental and neurodegenerative disease groups. Yellow numbers
at the base of bars represent sample size. (B) Protein sizes of zebrafish
orthologs of human disease genes with floating box plots (median with upper
and lower quartile-box and range-whiskers). Note some larger proteins are
outliers that fall outside of the calculated range. These gene sets for each
human disease only incorporate a small percentage of associated genes and
selection criteria varied because of the heterogeneity in genes linked to each
disease and an emphasis on producing conservative lists. Each gene set was
selected using data from research groups and review articles with the goal of
including only the highest confidence disease genes based on either statistical
thresholds and/or reoccurrence. Autism spectrum disorders (ASD) genes were
chosen from the Simons Foundation Autism Initiative (SFARI.org) “high
confidence” and “strong candidate” gene lists, which uses a multi-variable
scoring analysis that includes sample size, statistical significance, replication,
and functional analysis (Basu et al., 2009). ASD-intellectual disability (ID) genes
were found in four separate reviews that provide evidence for reoccurrence in
(Continued)
FIGURE 2 | Continued
both ASD and ID (Kaufman et al., 2010; Krumm et al., 2014; Srivastava et al.,
2014; Vissers et al., 2016). Schizophrenia (SCZ) genes were chosen from a
SCZ genetics review, however this list is small and does not provide a
confidence level for the disease contribution of each gene (Escudero and
Johnstone, 2014). X-linked ID genes (Piton et al., 2013) and Charcot-Marie
Tooth Disease (CMT; Timmerman et al., 2014) genes were chosen from recent
meta-analyses to which we included a threshold of >5 cases per gene.
Autosomal dominant and recessive and X-linked ataxia (ATX; Bird, 2016) and
Hereditary Spastic Paraplegia (HSP; Fink, 2014) genes were chosen with
well-known inheritance pedigrees. Human proteins for these gene lists were
generated using BioMart (Kinsella et al., 2011) and the longest isoforms were
used to identify zebrafish orthologs (Supplementary Material, Tables S1–7).
Human proteins were then Blasted (Flicek et al., 2014) against the zebrafish
proteome and ortholog information was recorded. Zebrafish proteins with low
percent coverage, protein identity, e-value and ambiguous gene annotation
(e.g., gene-like, LOC1084, etc.) were reciprocally blasted to confirm orthology.
Figure 2A). In comparison, ID, ATX and HSP zebrafish
orthologs had duplicate retention frequencies of 22–26% similar
to the estimated genome-wide (20–24%) duplicate retention rate
(Postlethwait et al., 2004; Howe et al., 2013). To determine
if neurodevelopmental processes were enriched in sets with
high duplicate retention rates we compared gene ortholog
Gene Ontology (GO) term enrichments within orthologs sets
(Mi et al., 2013). This program compares the frequency of a
biological term (e.g., neuron development) with the expected
frequency calculated for the genome. ASD (n = 35) and ASD-
ID (n = 22) orthologs showed enrichments for GO terms
associated with nervous system and neuronal development that
confirm large studies analyzing extensive data sets of ASD
and ID genes (Parikshak et al., 2013; Pinto et al., 2014). By
contrast, CMT orthologs (n = 19) did not show any GO term
enrichments overall, but those retained zebrafish CMTduplicates
were enriched in genes associated with neuronal development
(7/9 genes; Supplementary Material, Table S12). Therefore these
genes may be associated with earlier onset cases of CMT,
which can occur anywhere between birth and adulthood (De
Jonghe et al., 1997). Although these gene sets are small and
not statistically powerful, these rates show a general trend for
retaining duplicates associated with neural development.
To continue comparing these ortholog classes we looked
at the length of the longest protein-coding isoform for each
disease gene ortholog. This parameter impacts modeling due
to numerous exons and complex splicing. For example SH3
and multiple ankyrin repeat domain 3 (SHANK3) is a large
gene and mouse Shank3 knockout models exhibit variable
phenotypes depending on whether a mutation is expressed
in a predominant isoform (Peça et al., 2011; Zhou et al.,
2016). Therefore we compared protein sizes between disease
gene orthologs (Figure 2B). Between groups developmental
disorders all had larger median protein sizes when compared
to degenerative disease orthologs (Figure 2B). However, most
notably proteins encoded by ASD genes were more than twice
as long when compared to all degenerative disease proteins
(Figure 2B). Because ASD genes have been suggested to
encompass relatively large genes this result was perhaps not
surprising (King et al., 2013; Uddin et al., 2014). Together these
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results on isoform length and duplicate enrichment suggests that
ASD gene modeling in zebrafish will need to grapple with both
extensive gene duplication and large complex genes that present
challenges for knocking out all protein-coding isoforms and for
generating rescue constructs.
NEURODEVELOPMENTAL AND
NEURODEGENERATIVE ZEBRAFISH
MODELS
Developmental Disorders
Zebrafish models of developmental disorders have benefitted
from the accessible embryonic stages and simplified nervous
system that reveal an important role for signaling that patterns
in the early embryo. Developmental disorders including ASD, ID
and SCZ start to manifest phenotypically early in development
and include deficits in social, learning and occupational
functions (DSM-V). Because brain regions mediating human
cognitive symptomsmay lack parallels in zebrafish, modeling has
focused on embryonic development and disorder comorbidities
(such as sensory hypo-/hyper-sensitivity, sleep disruptions, and
epilepsy) that still allow testing of etiological theories for these
developmental disorders. These studies have paved the way for
comprehensive functional assessments that link cellular- and
circuit-level phenotypes to changes in behavior.
Molecular to Cellular Mechanisms: Signaling
Pathways and Head Size
Mounting evidence links the etiology of neurodevelopmental
disorders to embryonic stages. For example, teratogen exposure
during gestation can cause developmental disorders (Arndt et al.,
2005; Levy, 2011) and embryonic phenotypes in knockout mouse
models provide support for an embryonic component underlying
neurodevelopmental disorders (Knuesel et al., 2005; Lee et al.,
2011; Durak et al., 2015). Zebrafish knockdown models of ASD
and ID genes suggest that disrupted patterning of presumptive
neural tissue in developmental disorders can occur as early as
blastula stages (Yimlamai et al., 2005) and during gastrulation
(De Rienzo et al., 2011; Turner et al., 2015). At the molecular
level, these disruptions in patterning are likely due to changes
in conserved signaling pathways. Several ASD and SCZ zebrafish
models have investigated disease genes associated with the
Wnt pathway (De Rienzo et al., 2011; Bernier et al., 2014;
Brooks et al., 2014). For example, the Wnt interacting protein
Chromodomain Helicase DNA binding domain 8 (CHD8)
directly affects brain development during gastrulation and
increases the size of the optic tectum, mirroring macroencephaly
seen in ASD patients carrying CHD8 mutations (Bernier et al.,
2014; Sugathan et al., 2014). These genotype-specific features
(e.g., macrocephaly) provide a phenotypic screen that can be
used to investigate genetic classes within disorders. For example
zebrafish potassium channel tetramerization domain containing
13 (kctd13) was shown to have a dose-dependent affect
in producing macrocephaly (knockdown) and microcephaly
(overexpression) that supports a role for KCTD13 copy number
variants causing head size phenotypes (Golzio et al., 2012).
Moreover, Disrupted In Schizophrenia 1 (DISC1) interacts
with canonical and non-canonical Wnt signaling and zdisc1
morphants andmutants exhibit disorganized axon tracts at larval
stages that can be rescued by activatingWnt signaling (De Rienzo
et al., 2011). These studies provide clear examples of utilizing
zebrafish as an embryonic model to determine molecular and
cellular mechanisms that define morphological phenotypes seen
in individuals with developmental disorders.
Systems-Level Mechanisms: Disrupting the Balance
of Neuronal Activity
Mechanisms affecting neuronal activity can contribute to
neurodevelopmental disorders and zebrafish have been used to
relate circuit-level changes in activity to behavior (Rubenstein
and Merzenich, 2003; Eichler and Meier, 2008; Nelson and
Valakh, 2015; Scharf et al., 2015). Circuit-level changes
include disrupting the excitatory and inhibitory (E/I) balance,
an operational set-point of excitation and inhibition within
neural circuits that maintains functional behaviors (Borodinsky
et al., 2004; Gatto and Broadie, 2010; Turrigiano, 2012;
Vitureira et al., 2012; Davis, 2013). Zebrafish ASD and ID
models have looked at E/I balance using transgenic fish
lines expressing fluorescent glutamatergic (excitatory) and
GABAergic (inhibitory) neurons (Kozol et al., 2015; Hoffman
et al., 2016). Recently, Hoffman et al. found that populations of
GABAnergic neurons were significantly decreased in contactin
associated protein-like 2 (cntnap2ab) mutants, recapitulating
a mutant mouse Cntnap2 model and suggesting that in
the absence of cntnap2ab larvae fail to maintain inhibitory
neuronal populations. This inhibitory decrease was shown
to increase seizure susceptibility in cntnap2ab−/− mutants
by applying a GABA receptor antagonist (Hoffman et al.,
2016). In addition to seizure susceptibility, cntnap2ab−/−
mutants had increased nighttime activity providing a circadian
disruption for high-throughput drug screening. To identify
potential therapies, they screened for drugs that reduced
nighttime activity and identified a phytestrogen that restored
wild type-like activity states. Like decreased inhibition, increased
excitation is also known to contribute to developmental
disorders. One well-studied example of this is augmented
metabotropic glutamate receptor (mGluR) signaling in Fragile
X Syndrome (Scharf et al., 2015). Similar to Fragile x
mental retardation 1 (Fmr1) knockout models in mice, a
zebrafish fmr1 knockdown model showed behavioral deficits
that were ameliorated when treated with an mGluR inhibitor
(Tucker et al., 2006). These studies demonstrate how zebrafish
genetic models can be used to explore disorder etiology at
multiple levels and efficiently test molecular theories for drug
discovery.
Systems-Level Mechanisms: Comorbidities and
Connecting Cells to Behavior
Individuals with developmental disorders are more likely to
have accompanying medical conditions, or comorbidities, than
typically developing individuals (Gurney et al., 2006; American
Psychiatric Association, and DSM-5 Task Force, 2013; Chen
et al., 2013a). Non-cognitive comorbidities such as sensory
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hypo- or hyper-sensitivity, epilepsy and gastrointestinal (GI)
discomfort have revealed cellular-level mechanisms that may
underlie behavioral phenotypes in developmental disorders.
Several zebrafish knockdowns models of ASD, ID and epilepsy
genes have looked at impaired touch sensitivity. Knockdown
models of the ASD genes autism susceptibility candidate 2 (auts2)
and shank3a exhibit hyposensitivity with concomitant neuronal
cell death and morphological changes in skin innervating
sensory neurons (Oksenberg et al., 2013; Kozol et al., 2015).
Also exploring sensitivity, chromodomain helicase DNA binding
protein 2 (chd2) knockdowns and sodium channel, voltage
gated, type II, alpha (scn1lab) knockouts display hyper-excitable
phenotypes that are characterized by extended or disorganized
swimming with epileptiform-like activity in the brain (Baraban
et al., 2013; Suls et al., 2013; Galizia et al., 2015). These epileptic
swimming bouts provide a stereotyped behavior for high-
throughput drug screening. Such a screen in scn1lab mutants
identified anti-histamine clemizole as a novel anti-epileptic drug
(Baraban et al., 2013). Although more focus has been paid to
conditions such as epilepsy, other comorbidities like GI distress
in ASD have yet to be investigated comprehensively (Hsiao, 2014;
Bresnahan et al., 2015). For instance, chd8 morphants have a
decrease in HuC/D positive enteric neurons innervating the gut
and have impaired gut motility (Bernier et al., 2014). Again
this example provided a cellular to systems level mechanism
for GI distress seen in a majority of ASD patients carrying
a CHD8 mutation. These examples all show the utility of
zebrafish for studying comorbidities that impact the quality of
life of large cohorts of patients; therefore a better understanding
of the basis for these comorbidities would likely improve
patient care.
Hereditary Neurodegenerative Disorders
Some common cellular mechanisms underlying degenerative
diseases have been elucidated through gene discovery and
zebrafish modeling of rare hereditary diseases. The degeneration
of axon tracts in the central and peripheral nervous system
are a clinical feature in neurodegenerative disorders such as
Charcot-Marie-Tooth disease type 2 (CMT2), HSP, SMA or
spinal muscle atrophy (SMA), ALS, as well as some forms of
CATXwhich have phenotypic andmechanistic overlap (Züchner
and Vance, 2005; Timmerman et al., 2013; Bargiela et al., 2015;
Burté et al., 2015). The early development of zebrafish peripheral,
motor and sensory neurons provide a foundation that has been
used to dissect molecular mechanisms at both the cellular and
systems level especially in models of SMA and ALS (McGown
et al., 2013; Wiley et al., 2014). Using an innovative strategy
to develop SMA therapies, one study used a high-throughput
synthetic genetic array (SGA) screen in fission yeast to identify
gene networks that when targeted with drugs reversed motor
axon outgrowth deficits in a zebrafish SMA model (Wiley et al.,
2014). Zebrafish models of these neurodegenerative diseases
have also focused on molecular mechanisms such as axonal
transport, mitochondrial dynamics, and autophagy, while also
measuring morphological changes at the systems level such as
alterations at the neuromuscular junction, degeneration of motor
and sensory neurons, and disruptions of Purkinje cell (PC)
development.
Cellular Level Mechanisms: Axonal Transport
A subset of the causative genes in these disorders are directly
involved in axonal transport processes (Timmerman et al.,
2013). The optical transparency of zebrafish and transgenic
lines available make zebrafish an ideal model to study the
relationship between axonal transport and axon degeneration in
vivo (Pluci n´ska et al., 2012; O’Donnell et al., 2014). Mutations
in Kinesin Family member 5A (KIF5A), a molecular motor for
transporting microtubule-mediated cargo, have been reported
in both CMT2 (Crimella et al., 2012), and HSP patients
(Reid et al., 2002; Fichera et al., 2004). A kif5a mutant
zebrafish shows decreased touch response, and defective sensory
neuronal maintenance all within the larval stages of development
(Campbell et al., 2014). Furthermore the authors found that kif5a
specifically affects the transport and distribution of mitochondria
in neurons, but not lysosomes or presynaptic vesicles. Dominant
mutations in Atlastin GTPase 1 (ATL1) encoding atlastin-1 cause
an early onset form of HSP (Dürr et al., 2004). Morpholino
knockdown of atl1 in zebrafish causes decreased mobility in
larval fish and specifically disrupts axon tracts of spinal motor
neurons (Fassier et al., 2010). Fassier et al. (2010) further
demonstrated that the phenotype is the result of altered BMP
signaling and that atlastin may play a role in BMP receptor
trafficking. This link to BMP receptor trafficking suggested
blocking BMP receptors as a therapeutic strategy that indeed
ameliorated both cellular and behavioral phenotypes in the
atl1 morphant zebrafish model. These zebrafish models support
axonal transport as a cellular mechanism that could explain why
long axons in CMT2 and HSP are primarily affected by genetic
mutations in genes associated with transport processes.
Cellular Level Mechanisms: Mitochondrial
Neuropathies
Mitochondrial dysfunction is another common mechanism
in neurodegeneration. Dominant mutations in Mitofusin 2
(MFN2) are the primary cause of axonal degeneration in
Charcot-Marie-Tooth Neuropathy (CMT2), and MFN2 has
been implicated in the fusion and transport of mitochondria
in neurons (Chen et al., 2003; Züchner et al., 2004; Baloh
et al., 2007). Murine Mfn2 knockout and knock-in models are
embryonic or postnatal lethal and do not develop a peripheral
neuropathy, however a conditional knockout model did produce
cerebellar degeneration and neonatal lethality (Chen et al., 2003,
2007; Strickland et al., 2014). In contrast, a stable mfn2L285X
loss-of-function zebrafish model does recapitulate the motor
neuron degenerative phenotype showing progressive loss of
swimming ability, loss of neuromuscular junctions (NMJs),
and early lethality by 1 year of age (Chapman et al., 2013).
The authors found that the transport of mitochondria is
disrupted in cultured motor neurons from the homozygous
mfn2L285X at 24 hpf suggesting that a primary transport
defect occurs before the onset of symptoms. In addition to
axon degeneration of motor neurons a portion of patients
with MFN2 mutations also develop optic atrophy (Züchner
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et al., 2006). The optic nerve seems to be particularly
susceptible to mitochondrial dysfunction and is often affected
in clinical spectrum phenotypes classified as mitochondrial optic
neuropathies (Yu-Wai-Man et al., 2009). Recessive mutations
in the nuclear encoded mitochondrial gene Optic Atrophy 3
(OPA3) cause a spectrum disorder classified as Costeff syndrome
and includes optic atrophy, ataxia, extra pyramidal dysfunction,
and increased urinary excretion of 3-methylglutaconic acid
(MGC; Costeff et al., 1989). Zebrafish opa3 null mutants show
increased MGC at both 5 dpf and at 2–5 months (Pei et al.,
2010). At 1 year they show decreased optic nerve thickness
and retinal ganglion cell density. Mutants have detectable
changes in movement behaviors at larval stages and adults
show loss of horizontal swimming. The authors speculate
that the swimming phenotype can be attributed to ataxia,
however TUNEL and histological staining of the cerebellum
did not reveal any abnormalities. A third disease gene linked
to mitochondrial dynamics and a spectrum of degenerative
neurological conditions that include optic atrophy, CMT and
cerebellar degeneration is Solute Carrier family 25, member 46
SLC25A46; Abrams et al., 2015). Studies in zebrafish and patient
stem cells linked disruption of slc25a46 to reducedmitochondrial
fission, altered distribution of mitochondria in motor neurons,
and defective maintenance of neuronal processes. Even though
cellular phenotypes were dramatic, swimming deficits in slc25a46
morphants were mild.
Cellular Level Mechanisms: Cerebellar Purkinje
Neurons
Ataxia and associated sensory and motor phenotypes result
from genetic mutations that affect various cell types within the
spinocerebellar circuit. Cerebellar PCs are commonly affected
and appear especially sensitive to peroxisomal dysfunction
associated with PC loss or cerebellar atrophy (Akbar and
Ashizawa, 2015). Consistent with this, zebrafish ataxia models,
such as sorting nexin 14 (snx14) morphants show decreases in
PC progenitors while cwf19-like 1 (cwf1911) morphants show
disruptions in overall hindbrain morphology (Burns et al., 2014;
Akizu et al., 2015). Alternatively, one group has focused on
primary motor neurons for functional studies of Potassium
Channel, voltage gated shaw related subfamily c, member 3
(KCN3) mutations that cause Spinocerebellar ataxia type 13
(Waters et al., 2006). They found that zebrafish kcn3a is
expressed in the primary motor neurons and overexpression of
a dominant negative version of this potassium channel decreases
in neuronal excitability during fictive swimming (Issa et al.,
2012). To follow up this study, Issa et al. also investigated the
affect of KCN3 mutations associated with infant onset ataxia.
Overexpression of two human KCN3 mutations demonstrated
axonal defects that were only found in a mutation associated
with infantile onset of SCA13. Given that neurodegenerative
phenotypes become more severe with age, there has been doubt
as to whether modeling these diseases in zebrafish larvae would
be informative. The studies reviewed above indicate that indeed
it is possible to gain functional insight into the basic biology of
these disease genes frommodeling in the larva. As a newermodel,
however, approaches in zebrafish are not quite as standardized
as those in longer established models like Drosophila and
mouse resulting in the diversity of modeling strategies employed
by different researchers to model these inherited neurological
conditions.
LESSONS LEARNED FROM MODELING
INHERITABLE DISEASE GENES
Homeostatic Plasticity: Unlinking Cellular
and Systems Level Phenotypes
In some less common examples, genetic mutations cause
cellular- and molecular-level phenotypes without leading to
behavioral phenotypes. In zebrafish where’s waldo and strumpy
mutants, neuromuscular synaptogenesis is defected but the
mutants exhibit normal motility (Hutson and Chien, 2002;
Panzer et al., 2005). Similar phenomena have been observed
in mouse hypoxanthine-guanine phosporibosyltransferase
(HPRT) and HPRT-adenine phosporibosyltransferase (APRT)
mutant models of Lesch-Nyhan syndrome genes that produced
an expected drop in dopamine but lacked self mutilation
behaviors (Kuehn et al., 1987; Engle et al., 1996; Jinnah
et al., 1999). These observations indicate that molecular-
and cellular-level phenotype does not always correspond to
behavioral phenotype, suggesting the existence of compensatory
mechanisms at the systems-level. Besides genetic compensation
from other genes, the nervous system also has remarkable
capacity to stabilize its functions via homeostatic plasticity.
Compensatory homeostatic plasticity operates on multiple
levels, regulating synaptogenesis, synaptic strength and intrinsic
excitability to stabilize neural circuit output in the context of
genetic and/or environmental perturbations (Turrigiano, 2012;
Vitureira et al., 2012; Davis, 2013). In zebrafish strumpyp37er
mutants have enlarged NMJ acetylcholine receptor clusters are
compared to wild-type (Panzer et al., 2005), but lack motor
phenotypes, indicating homeostatic plasticity. In addition,
defective homeostatic plasticity has been associated to a variety
of human neurological diseases, including ASD, ID and Fragile X
Syndrome (Rubenstein and Merzenich, 2003; Eichler and Meier,
2008; Gatto and Broadie, 2010; Yizhar et al., 2011; Wondolowski
and Dickman, 2013; Nelson and Valakh, 2015). Mutant animal
models with cellular but not behavioral phenotype have the
potential to shed light on mechanisms of homeostatic plasticity
at the systems-level. Given the diversity of molecular genetic
pathways that contribute to developmental and degenerative
disorders, a potential therapeutic target is to boost compensatory
mechanisms that act to re-establish systems-level function.
Genetic Buffering: Molecular
Compensation for Genetic Lesions
It is also common, though not necessarily well-represented in
the literature, for knockout models to lack phenotypes. In a
zebrafish study that generated mutant lines with 32 distinct
lesions in 24 genes, most of the mutants exhibit a wild-type
phenotype (Kok et al., 2015). Rather than a unique characteristic
of zebrafish, such phenotypic buffering is found across single-
celled to multi-cellular organisms. For example, >70% in fission
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yeast and >80% in bakers yeast, of genes can be individually
mutated with little effect on haploid viability in the laboratory
setting (Kim et al., 2010)1. Also in mice, though it is hard to
accurately estimate the proportion of knockout mice without
detectable phenotypes due to a lack of publications, the number
is considerable (Barbaric et al., 2007). This phenomenon can
be explained by the recent finding that other genes in a
regulatory network can provide genetic compensation inmutants
(Rossi et al., 2015). Such compensation can vary depending
on genetic background (Gerlai, 1996; Pearson, 2002). Another
recent study in zebrafish shows that the oncogenic B-RAF
proto-oncogene (BRAFV600E) mutations rarely covert carrier
cells into cancer cells unless in a p53 mutant background
(Kaufman et al., 2016). The importance of genetic background
for gene regulatory compensation likely contributes to disease
penetrance and expressivity in humans as well (Zlotogora, 2003;
Andersen and Al-Chalabi, 2011; Cooper et al., 2013; Persico and
Napolioni, 2013), and suggests the importance to move from
analyzing single gene to systems-level analysis of gene regulatory
networks in disease models (Döhr et al., 2005; Barabási et al.,
2011; Chen et al., 2014; Wiley et al., 2014; Marbach et al.,
2016).
Broad Gene Expression; Local Pathology
Both developmental and degenerative diseases are associated
with dysfunction in specific regions of the CNS (Figure 1).
None-the-less most genes have heterogeneous spatial and
temporal expression patterns that extend well beyond the
windows of time and specific neural circuits associated with
the disorder. Therefore we did a limited meta-analysis of
mRNA expression of zebrafish disease orthologs. Unfortunately
a zebrafish gene expression atlas does not exist and the
most complete data sets only span embryonic development.
Therefore we chose to compile previously published in situ
hybridization data and determine the relative enrichment of
gene expression in brain regions and spinal cord (Figure 3;
Suplementary Material, Tables S13–18). During the first day
of development, both gene sets show enriched expression in
the hindbrain with the developmental set having enriched
expression in the forebrain. By the second and third day,
expression patterns become broader showing similar enrichment
throughout the brain at these stages of morphogenesis and
circuit formation. Broad CNS expression patterns suggest
that genes play functional roles throughout development and
across the nervous system despite being associated with
symptoms that disrupt specific circuits during particular times
of life.
LOOKING FORWARD: NEURAL CIRCUITS,
BEHAVIOR, AND THERAPY
Because of the large number of rare mutations linked to
inherited nervous system diseases, an important frontier for
disease modeling is strategies that leverage to make stable F0
mutant models of inherited neurological disorders (Jao et al.,
1http://www.yeastgenome.org
FIGURE 3 | Comparing relative central nervous system (CNS) gene
expression for developmental and degenerative disease gene
orthologs in zebrafish. Previously published in situ hybridization data was
collected from the zebrafish model organism database (ZFIN.org). Expression
level was scored for each gene proportionally from 0 to 3; 0, no expression; 1,
expression; 2, moderate expression; and 3, high level of expression, (i.e., gene
x showed expression in the telencephalon (1) at 12 hpf and comparatively high
expression in the telencephalon (3) at 36 hpf). Zebrafish larvae illustrations
were adapted from Kimmel et al. (1995). D, diencephalon; M, mesencephalon;
R, rhombencephalon; T, telencephalon and SC, spinal cord (De Jonghe et al.,
1997; Kudoh et al., 2001; Thisse et al., 2001; Wurst and Bally-Cuif, 2001;
Groth et al., 2002; Rauch et al., 2003; Thisse and Thisse, 2004, 2005;
Croushore et al., 2005; Imamura and Kishi, 2005; Meyer et al., 2005;
Thompson et al., 2005; Yimlamai et al., 2005; Liu et al., 2006; Mendelsohn
et al., 2006; Meyer and Smith, 2006; Cheng et al., 2007; George et al., 2007;
Goruppi et al., 2007; Katsuyama et al., 2007; Patten et al., 2007; Anichtchik
et al., 2008; Stuebe et al., 2008; Sun et al., 2008; Yoshida and Mishina, 2008;
Zhou et al., 2008; Emond et al., 2009; Ferrante et al., 2009; Monnich et al.,
2009; Patten and Ali, 2009; Titus et al., 2009; Wood et al., 2009; Appelbaum
et al., 2010; Davey et al., 2010; Fassier et al., 2010; Rissone et al., 2010;
Takada and Appel, 2010; Mapp et al., 2011; Yeh et al., 2011; Artuso et al.,
2012; Dresner et al., 2012; Gomez et al., 2012; Imai et al., 2012; Mueller,
2012; Pujol-Martí et al., 2012; Xing et al., 2012; Yanicostas et al., 2012;
Baraban et al., 2013; Campbell and Marlow, 2013; Haug et al., 2013; Ng
et al., 2013; Recher et al., 2013; Suls et al., 2013; Vatine et al., 2013; Bernier
et al., 2014; Garbarino et al., 2014; Housley et al., 2014; Hsieh et al., 2014;
Galizia et al., 2015; Kozol et al., 2015; Wakayama et al., 2015).
2013; Shah et al., 2015). Such models enable the rapid screening
of candidate disease genes for whether they produce disease
relevant phenotypes in the zebrafish model. To this end, many
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groups currently augment their MO studies by demonstrating
similar phenotypes in F0 mutants (Bernier et al., 2014; Aspatwar
et al., 2015; Bögershausen et al., 2015; O’Rawe et al., 2015;
Wheeler et al., 2015; Xing et al., 2015). Still others have found
mismatches between morphant and stable mutant phenotypes
(Kok et al., 2015; Rossi et al., 2015; Stainier et al., 2015). Clearly
in some cases these mismatches ascribed to non-specific effects
of the morpholino (Kok et al., 2015) can also be explained
by compensatory mechanisms masking the phenotype in the
stable mutant (Rossi et al., 2015). To address the challenges
of gene duplicates and multiple mutation causes of disease
(Shah et al., 2015), several labs have further pioneered a
strategy to pool guides targeting multiple genes and inject
them together to efficiently screen multiple mutations in the
F0 generation. Combined with a large repertoire of behaviors
that develop within 5 days of fertilization and diverse transgenic
lines for rapid screening of cellular phenotypes, F0 CRISPR
zebrafish mutagenesis promises to contribute significantly to
our understanding of genetic variation linked to nervous system
disorders.
To model specific patient missense mutations and to
better understand the basic biology of disease genes by tagging
them in vivo or create conditional mutant alleles, several groups
have also recently pioneered the use CRISPR/Cas9 for more
sophisticated genome engineering. One novel strategy effectively
‘‘enhancer traps’’ a gene of interest by replacing the last exon
with an engineered last exon encoding the C-terminal end of
the coding sequence in frame with a cleavable p2A sequence
followed by a fluorescent reporter (Li et al., 2015). In this way,
the spatial and temporal expression dynamics of the protein
can be captured. Also recently, Hoshijima et al. (2016) have
developed streamlined strategies to precisely edit the genome
and generate conditional mutant alleles flanked by LoxP sites.
Such conditional mutant alleles have been used to great effect in
mousemodels to test when themutation acts to produce different
disease phenotypes. For example, in a mouse Shank3 autism
model, rescuing the mutant Shank3 protein in the adult was
sufficient to rescue social interactions and excessive grooming
but not anxiety and repetitive motor behaviors (Mei et al., 2016).
The development of approaches that enable monitoring of
behavior-relevant neural circuits in the intact larvae will be
a boon for modeling inherited neurological disease (Ahrens
et al., 2013; Fosque et al., 2015; Randlett et al., 2015; Dunn
et al., 2016). Such approaches have the significant advantage
of being unbiased. While many of these systems-level analyses
use light-sheet or high-end microscopy to capture data (Ahrens
et al., 2013; Fosque et al., 2015; Dunn et al., 2016), others
use standard confocal microscopy to identify relevant brain
circuits (Randlett et al., 2015) that are often spatially distributed
across the nervous system. Several groups have also made
concerted efforts towards establishing brain atlases to structurally
and functionally annotate the brain (Ronneberger et al., 2012;
Turner et al., 2014; Randlett et al., 2015) which is crucial since
the ability to interpret imaging data is only as good as our
understanding of brain regions (Arrenberg and Driever, 2013).
Once these circuits are identified, they can then be studied in
greater depth using in vivo calcium imaging with genetically
encoded calcium indicators- (GECIs; Chen et al., 2013b), laser
or enzymatic ablation of parts of the circuit (Liu and Fetcho,
1999; Tabor et al., 2014; Chen et al., 2016), electrophysiological
recordings (Koyama et al., 2011; Baraban, 2013; Johnston et al.,
2013; Wen et al., 2013), and optogenetics (Wyart et al., 2009;
Kimura et al., 2013) to dissect circuit properties. Most of
these approaches have yet to be broadly applied to zebrafish
models of disease but once applied more broadly they promise
to significantly contribute to our understanding of systems-
level neural circuit mechanisms that contribute to symptoms of
inherited neurological disorders.
In addition to genetic screens, due to their small size and
their tendency to absorb drugs added directly to the water,
zebrafish larvae are uniquely amenable for high-throughput drug
screens (Rihel et al., 2010; Rihel and Schier, 2013; Bruni et al.,
2014). High-throughput behavioral screens in zebrafish have
enabled the classification of neuro-active drugs with respect to
their impact on whole organism behavior. The ability to screen
compounds in this manner is crucial since neuroactive drug
discovery is still more empirical—amatter of what works—rather
than rational—a matter of what makes sense based on chemistry
and known molecular targets (Bruni et al., 2014). As highlighted
in neurodevelopmental and neurodegenerative sections above,
several disease models have made great use of the ability to use
drugs to enhance or suppress mutant phenotypes as a means to
identify therapeutic strategies (Fassier et al., 2010; Baraban et al.,
2013; Hoffman et al., 2016).
CONCLUSION
The continued expertise and innovations of zebrafish genetic
and developmental tools will continue to make zebrafish an
attractive neurological disease model. Going forward, combining
standard assays that allow comparisons acrossmodels with newer
approaches would be ideal to enable a better understanding
of the molecular, cellular, and systems-level groupings of
these neurological conditions. Finally, zebrafish will certainly
contribute to consortia of research groups that use multiple
animal models for discovering essential molecular to circuit level
mechanisms underlying neurological disease.
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